Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Helius Medical Technologies Inc. HSDT

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources.


Recent & Breaking News (NDAQ:HSDT)

Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022

GlobeNewswire 11 days ago

Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023

GlobeNewswire January 19, 2023

Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program

GlobeNewswire January 10, 2023

Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis

GlobeNewswire January 5, 2023

Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk

GlobeNewswire January 3, 2023

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire December 30, 2022

Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results

GlobeNewswire November 14, 2022

Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program

GlobeNewswire November 9, 2022

Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program

GlobeNewswire November 8, 2022

Helius to Showcase Innovative PoNS Device at ACRM's 2022 Conference - Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait

GlobeNewswire November 3, 2022

Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022

GlobeNewswire November 1, 2022

Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait

GlobeNewswire October 13, 2022

Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference

GlobeNewswire September 29, 2022

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire September 14, 2022

Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September

GlobeNewswire September 6, 2022

Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results

GlobeNewswire August 15, 2022

Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022

GlobeNewswire August 10, 2022

Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering

GlobeNewswire August 5, 2022

Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy(TM)

GlobeNewswire July 12, 2022

Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers ("CMSC") Annual Meeting

GlobeNewswire June 6, 2022